Chiron Real Estate Inc.
Close on Oct 19, 2026
- Market cap
- $392.42M
- P/E (TTM)
- 8.0
- Dividend yield
- –
About Chiron Real Estate
Real Estate Investment Trusts, SIC 6798
Chiron Real Estate Inc. is an internally managed real estate investment trust that acquires and owns healthcare real estate properties. The company focuses on off-campus medical facilities, small to mid-sized healthcare assets in secondary markets and suburban areas, and residential communities for seniors. Its property types primarily comprise medical office buildings, inpatient rehabilitation facilities, and surgical hospitals, alongside other specialized clinical spaces. Chiron Real Estate leases its facilities mainly to physician practice groups, regional healthcare systems, and national healthcare operators.
The company's real estate portfolio comprises 189 buildings spanning approximately 5.1 million leasable square feet, along with an interest in an unconsolidated joint venture owning two additional healthcare facilities. Chiron Real Estate maintains properties across 35 states in the United States, with notable concentrations in Texas, Florida, Ohio, Arizona, Pennsylvania, and Illinois. The provided text states that the entity is a Maryland corporation, but it does not specify its headquarters location.
Summary of the business section of Chiron Real Estate's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Chiron Real Estate Inc.
- Headquarters
- Bethesda, MD
- Address
- 7373 Wisconsin Avenue, Suite 800 20814
- Phone
- (202) 524-6851
- Employees
- 30, Dec 31, 2025
- Industry
- Real Estate Investment Trusts
- Incorporated in
- Maryland
- Fiscal year ends
- December 31
- Auditor
- Deloitte & Touche LLP, McLean, VA
Stock & identifiers
- Ticker
- XRN
- Other tickers
- XRN.PA, XRN.PB
- Exchange
- NYSE
- Shares outstanding
- 13M, Aug 3, 2026
- Public float
- $436.00M, Jun 30, 2025
- Filer category
- Accelerated filer
- Stock splits
- 1-for-5 reverse, Sep 22, 2025; 1-for-5 reverse, Sep 19, 2025; 1-for-400 reverse, Dec 19, 2014
- SEC CIK
- 1533615
- CUSIP
- 37954A303
- ISIN
- US37954A3032
- LEI
- 549300HFRIPQDYU3GU60
- EIN
- 46-4757266
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Mark Okey Decker Jr | CEO and President, Director | 78,603 |
| Jeffrey Busch | Chairman, President and CEO, Director | 43,490 |
| Matthew Fitzsimmons Whitlock | Chief Investment Officer | 2,000 |
| Danica Holley | Chief Administrative Officer | 1,590 |
| Aaron Robert Roseth | COO | 13,500 |
| Robert Harold Zeiller | See Remarks | – |
| Jamie Allen Barber | General Counsel and Secretary | 1,481 |
| Robert J. Kiernan | CFO and Treasurer | 6,000 |
| Alfonzo Leon | CIO | – |
| Charles Fitzgerald | Director | 138,893 |
| Paula Crowley | Director | 1,000 |
| Lori Wittman | Director | 2,940 |
| Matthew Cypher | Director | 1,690 |
| Ronald Marston | Director | 10,596 |
| Henry Cole | Director | 9,286 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Jeffrey Busch | $328.61K | $36.88K | $1.22M | $78 | $114 |
| FY2025 Mark Decker Jr | $1.82M | $1.95M | $1.22M | $78 | $114 |
| FY2024 Jeffrey Busch | $2.52M | $1.95M | $1.21M | $86 | $124 |
| FY2023 Jeffrey Busch | $2.18M | $2.52M | $1.14M | $112 | $114 |
| FY2022 Jeffrey Busch | $1.84M | -$1.03M | $915.64K | $88 | $100 |
| FY2021 Jeffrey Busch | $1.51M | $2.87M | $751.96K | $152 | $132 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of December 31, 2025, the Company had 30 employees.”
Corporate history
Events identified from SEC filings